---
status: clean
reviewed_at: 2026-06-01
---

# Phase 119 Code Review

## Scope Reviewed

- `scripts/build_prerelease_artifact_bundle.py`
- `tests/sol_execbench/test_prerelease_artifact_bundle.py`
- `docs/prerelease_artifact_bundle.md`
- Claim-boundary wording updates for the MI300X/CDNA3 relationship.

## Findings

No blocking findings.

## Notes

- The bundle script keeps release validation blocking while treating environment evidence as diagnostic/unavailable when host tooling is absent.
- Authority classes are validated against the full required set: `canonical`, `diagnostic-only`, `provisional`, `deferred`, and `unavailable`.
- Transcript tails reuse credential redaction patterns from release-candidate validation.
- The MI300X wording now states that MI300X is the concrete CDNA3 `gfx942` hardware target, not a separate architecture target.

## Residual Risk

- The default validation command is CPU-safe but still depends on local `uv` environment health.
- Phase 120 should add explicit release-readiness gates around generated bundle completeness.
